{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:25:08Z","timestamp":1761128708609},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1157\/13128781","type":"journal-article","created":{"date-parts":[[2008,11,22]],"date-time":"2008-11-22T12:56:56Z","timestamp":1227358616000},"page":"54-60","source":"Crossref","is-referenced-by-count":10,"special_numbering":"S13","title":["Tuberculosis multirresistente"],"prefix":"10.1016","volume":"26","author":[{"given":"Fernando","family":"Alcaide","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Sant\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13128781_bib1","unstructured":"World Health Organization. Global tuberculosis control: surveillance, planning, financing: WHO report 2008. WHO Press, 2008. WHO\/HTM\/TB\/2008. 393."},{"key":"10.1157\/13128781_bib2","unstructured":"The WHO\/IUATLD Global project on anti-tuberculosis drug resistance surveillance. Anti-tuberculosis drug resistance in the World 2002-2007. Fourth Global Report. World Health Organization, WHO Press, 2008. WHO\/HTM\/TB\/2008.394."},{"key":"10.1157\/13128781_bib3","unstructured":"World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. WHO Press, 2006. WHO\/HTM\/TB\/2006.361."},{"key":"10.1157\/13128781_bib4","first-page":"301","article-title":"Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004","volume":"55","author":"Wright","year":"2006","journal-title":"MMWR"},{"key":"10.1157\/13128781_bib5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1056\/NEJM199302253280801","article-title":"The emergence of drug-resistant tuberculosis in New York City","volume":"328","author":"Frieden","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1157\/13128781_bib6","unstructured":"EuroTB (InVS\/KNCV) and the national coordinators for tuberculosis surveillance in the WHO European Region. Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2005. Sain-Maurice, France: Institut de Veille Sanitaire; 2007."},{"key":"10.1157\/13128781_bib7","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/S0140-6736(97)07567-3","article-title":"Nosocomial transmisi\u00f3n of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection","volume":"350","author":"Guerrero","year":"1997","journal-title":"Lancet"},{"key":"10.1157\/13128781_bib8","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/JCM.43.3.1220-1227.2005","article-title":"Spanish Working Group on MDR-TB. Systematic molecular characterization of multidrug-resistant Mycobacterium tuberculosis complex isolates from Spain","volume":"43","author":"Samper","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13128781_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1126\/science.118.3063.297","article-title":"Some observation on the pathogenicity of isoniazid-resistant variants tubercle bacilli","volume":"118","author":"Middlebrook","year":"1953","journal-title":"Science"},{"key":"10.1157\/13128781_bib10","series-title":"Molecular genetics of mycobacteria","first-page":"235","article-title":"Genetics of drug resistance in Mycobacterium tuberculosis","author":"Zhang","year":"2000"},{"key":"10.1157\/13128781_bib11","series-title":"Procedimientos en Microbiolog\u00eda Cl\u00ednica. Recomendaciones de la Sociedad de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica (Protocolo 9a)","article-title":"Micobacterias","author":"Alcaide","year":"2005"},{"key":"10.1157\/13128781_bib12","series-title":"Manual of clinical microbiology","first-page":"1223","article-title":"Susceptibility test methods: mycobacteria, Nocardia, and other actinomycetes","author":"Woods","year":"2007"},{"key":"10.1157\/13128781_bib13","series-title":"Susceptibility testing for mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard. NCCLS document M24-A","year":"2003"},{"key":"10.1157\/13128781_bib14","first-page":"748","article-title":"Quality Reference Laboratory Network: five rounds of proficiency testing, 1994-1998","volume":"6","author":"Laszlo","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1157\/13128781_bib15","series-title":"Guidelines for drug susceptibility testing for second-line anti-tuberculosis drugs for DOTS-plus","year":"2001"},{"key":"10.1157\/13128781_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1128\/JCM.44.1.201-205.2006","article-title":"Use of a mycobacteriophage-based assay for rapid assessment of susceptibilitie s of Mycobacterium tuberculosis isolates to isoniazid and influence of resistance level on assay performance","volume":"44","author":"Gal\u00ed","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13128781_bib17","series-title":"Tuberculosis and the Tubercle Bacillus","first-page":"89","article-title":"Molecular diagnosis of mycobacterial infections","author":"Forbes","year":"2005"},{"key":"10.1157\/13128781_bib18","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1128\/JCM.40.3.988-995.2002","article-title":"New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis","volume":"40","author":"Garc\u00eda de Viedma","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13128781_bib19","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/jac\/dki132","article-title":"Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes","volume":"55","author":"Espasa","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1157\/13128781_bib20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/jac\/dkl058","article-title":"Rapid detection of specific gene mutations associated with isoniazid and rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays","volume":"57","author":"Arag\u00f3n","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1157\/13128781_bib21","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1128\/JCM.44.2.350-352.2006","article-title":"Comparison of two commercially available DNA line assays for detection of multidrug-resistant Mycobacterium tuberculosis","volume":"44","author":"M\u00e4kinen","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13128781_bib22","first-page":"213","article-title":"Levels of Laboratory services of micobacterial disease: official statement of the American Thoracic Society","volume":"128","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"10.1157\/13128781_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0196-4399(95)80028-X","article-title":"Resistance and susceptibility testing for Mycobacterium tuberculosis","volume":"17","author":"Klietmann","year":"1995","journal-title":"Clin Microbiol Newsl"},{"key":"10.1157\/13128781_bib24","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: Treatment of tuberculosis","volume":"167","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1157\/13128781_bib25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0025-7753(00)71603-4","article-title":"Farmacorresistencia de Mycobacterium tuberculosis. Estudio multic\u00e9ntrico en el \u00e1rea de Barcelona","volume":"115","author":"Mart\u00edn-Casabona","year":"2000","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13128781_bib26","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0140-6736(04)15496-2","article-title":"Programmes and principles in treatment of multidrug-resistant tuberculosis","volume":"363","author":"Mukherjee","year":"2004","journal-title":"Lancet"},{"key":"10.1157\/13128781_bib27","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1086\/428582","article-title":"Treatment of multidrug resistant tuberculosis in San Francisco: an outpatient-based approach","volume":"40","author":"Burgos","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128781_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/0003-4819-117-3-184","article-title":"Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multidrug-resistant bacilli","volume":"117","author":"Fischl","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1157\/13128781_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3201\/eid0202.960208","article-title":"Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in Spain","volume":"2","author":"Rullan","year":"1996","journal-title":"Emerg Infect Dis"},{"key":"10.1157\/13128781_bib30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1128\/CMR.8.2.180","article-title":"Tuberculosis in the AIDS era","volume":"8","author":"Sepkowitz","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1157\/13128781_bib31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM199302253280802","article-title":"Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin","volume":"328","author":"Goble","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1157\/13128781_bib32","first-page":"829","article-title":"Treatment of multidrug-resistant tuberculosis: evidence and controversies","volume":"10","author":"Caminero","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1157\/13128781_bib33","first-page":"887","article-title":"Determinants of drug-resistant tuberculosis: analysis of 11 countries","volume":"5","author":"Espinal","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1157\/13128781_bib34","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1128\/JCM.31.4.771-775.1993","article-title":"Current practices in mycobacteriology: results of a survey of state public health laboratories","volume":"31","author":"Huebner","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13128781_bib35","first-page":"489","article-title":"Working alliance for TB drug development, Cape Town, South Africa, February 8th, 2000. Declaration","volume":"4","author":"Pablos-M\u00e9ndez","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1157\/13128781_bib36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nm0307-290","article-title":"Challenges in tuberculosis drug research and development","volume":"13","author":"Ginsberg","year":"2007","journal-title":"Nat Med"},{"key":"10.1157\/13128781_bib37","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jac\/dki148","article-title":"Linezolid for the treatment of multidrug-resistant tuberculosis","volume":"56","author":"Fort\u00fan","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1157\/13128781_bib38","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJM199404283301702","article-title":"The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis","volume":"330","author":"Weis","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1157\/13128781_bib39","first-page":"1","article-title":"Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care setting, 2005","volume":"54","author":"Jensen","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1157\/13128781_bib40","first-page":"19","article-title":"Treatment of latent tuberculosis in persons at risk for multidrug-resistant tuberculosis: systematic review","volume":"10","author":"Fraser","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1157\/13128781_bib41","first-page":"131","article-title":"Adverse events associated with pyrazinamide and levofloxacin in the treatment of the latent multidrug-resistant tuberculosis","volume":"167","author":"Papastavros","year":"2002","journal-title":"CMAJ"},{"key":"10.1157\/13128781_bib42","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1086\/504325","article-title":"Trends in drug-resistant Mycobacterium tuberculosis in New York City, 1991-2003","volume":"42","author":"Munsiff","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128781_bib43","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1473-3099(07)70143-3","article-title":"Predicting the future of XDR tuberculosis","volume":"7","author":"Blower","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1157\/13128781_bib44","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1472-9792(02)00058-6","article-title":"The global situation of MDR-TB","volume":"83","author":"Espinal","year":"2003","journal-title":"Tuberculosis"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X08765832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X08765832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T15:01:35Z","timestamp":1589122895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X08765832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":44,"alternative-id":["S0213005X08765832"],"URL":"https:\/\/doi.org\/10.1157\/13128781","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}